2022 GRACI Foundation Grant Recipients
2022 General GRACI Grant
Recipient Name: Michelle Wilson
Recipient Organisation: Cancer and Blood Services, Auckland City Hospital
Grant Value: $29,988.00
Grant Purpose
Phase II basket study of an aromatase inhibitor plus PI3KCA inhibitor CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic gynaecological neoplasms-PARAGON-II
2022 Cure Our Ovarian Cancer Grants - GRACI in Collaboration with Cure Our Ovarian Cancer
Grant 1
Recipient Name: Mak Sarwar
Recipient Organisation: Department of O & G, University of Otago, Christchurch
Grant Value: $20,000.00
Grant Purpose
Investigation of dual Src/MEK targeting in low-grade serous ovarian cancer (as part of a SMILE study - Src MEK Inhibition for Low-grade ovarian cancer elimination).
Grant 2
Recipient Name: Kenny Chitcholtan
Recipient Organisation: Department of O & G, University of Otago, Christchurch
Grant Value: $20,000.00
Grant Purpose
Combination of re-purposed iron-chelating and anti-malarial drugs to overcome autphagy cell survival in ovarian cancer.
Grant 2
Recipient Name: Magdalena Ratajska
Recipient Organisation: Department of Pathology, University of Otago
Grant Value: $20,000.00
Grant Purpose
Targeted molecular profiling of epithelial ovarian cancer in New Zealand patients.
2022 General GRACI Grant
Recipient Name: Michelle Wilson
Recipient Organisation: Cancer and Blood Services, Auckland City Hospital
Grant Value: $29,988.00
Grant Purpose
Phase II basket study of an aromatase inhibitor plus PI3KCA inhibitor CDK4/6 inhibitor in women with hormone receptor positive recurrent/metastatic gynaecological neoplasms-PARAGON-II
2022 Cure Our Ovarian Cancer Grants - GRACI in Collaboration with Cure Our Ovarian Cancer
Grant 1
Recipient Name: Mak Sarwar
Recipient Organisation: Department of O & G, University of Otago, Christchurch
Grant Value: $20,000.00
Grant Purpose
Investigation of dual Src/MEK targeting in low-grade serous ovarian cancer (as part of a SMILE study - Src MEK Inhibition for Low-grade ovarian cancer elimination).
Grant 2
Recipient Name: Kenny Chitcholtan
Recipient Organisation: Department of O & G, University of Otago, Christchurch
Grant Value: $20,000.00
Grant Purpose
Combination of re-purposed iron-chelating and anti-malarial drugs to overcome autphagy cell survival in ovarian cancer.
Grant 2
Recipient Name: Magdalena Ratajska
Recipient Organisation: Department of Pathology, University of Otago
Grant Value: $20,000.00
Grant Purpose
Targeted molecular profiling of epithelial ovarian cancer in New Zealand patients.